Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2016

Oct 4, 2016

29745_dirs_2016-10-04_75c199a1-16d6-457b-9019-78dd75157c95.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2016-10-02

Reporting Person: Barnes Melissa S (Chief Eth/Cmpl Ofcr & SVP, ERM)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-10-02 Common Stock M 3894 Acquired 12063 Direct
2016-10-02 Common Stock F 1801 $80.26 Disposed 10262 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-10-02 Restricted Stock Unit $ M 3894 Disposed 2016-10-02 Common Stock (3894.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 847 Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.